Skin and Soft Tissue Infections in Non-Human Immunodeficiency Virus Immunocompromised Hosts

Infect Dis Clin North Am. 2021 Mar;35(1):199-217. doi: 10.1016/j.idc.2020.10.009. Epub 2020 Dec 7.

Abstract

Skin and soft tissue infections among the non-human immunodeficiency virus infected immunosuppressed population are a serious and growing concern. Many pathogens can cause cutaneous infections in these patients owing to the highly varied and profound immune deficits. Although patients can be infected by typical organisms, the diversity and antimicrobial-resistant nature of the organisms causing these infections result in significant morbidity and mortality. The diagnostic approach to these infections in immunocompromised hosts can differ dramatically depending on the potential causative organisms. An understanding of new immunosuppressive treatments and evolving antimicrobial resistance patterns are required to optimally manage these difficult cases.

Keywords: Antimicrobial resistance; Fungal infection; Immunocompromised host; Necrotizing fasciitis; Skin infection.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Bacterial Infections / therapy
  • Drug Resistance, Microbial
  • Environmental Exposure
  • Fasciitis, Necrotizing / therapy
  • HIV Seronegativity
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects
  • Mycoses / therapy
  • Skin Diseases, Infectious / diagnosis
  • Skin Diseases, Infectious / immunology
  • Skin Diseases, Infectious / therapy*
  • Soft Tissue Infections / diagnosis
  • Soft Tissue Infections / immunology
  • Soft Tissue Infections / therapy*
  • Virus Diseases / therapy

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Immunosuppressive Agents